AstraZeneca investors raise concerns over mega-merger talks

1 week ago 23

Want Your Business Featured Here?

Get instant exposure to our readers

Chat on WhatsApp
Shareholders question looming patent cliff and antitrust risks in potential $400bn tie-up with Bristol Myers Squibb
Read Entire Article
Chatroom